Intraventricular chemotherapy in neonatal meningitis

Area of Science:

• Neonatalogy
• Infectious Diseases
• Pediatric Neurology

Background:

• Neonatal meningitis is a serious infection in newborns.
• Ventriculitis frequently accompanies neonatal meningitis, posing treatment challenges.
• Gram-negative organisms are common causative agents.

Purpose of the Study:

• To evaluate the efficacy of intraventricular antibiotic chemotherapy as an adjunct to systemic treatment for neonatal meningitis with ventriculitis.
• To assess the impact of this combined treatment approach on mortality and neurological outcomes.

Main Methods:

• A cohort of 16 infants with neonatal meningitis was treated over 30 months.
• All infants received systemic and intraventricular antibiotics.
• Antibiotic concentrations in cerebrospinal fluid were monitored during treatment.

Main Results:

• 15 out of 16 infants had concurrent ventriculitis, predominantly gram-negative.
• 15 infants survived the infection.
• Seven of the survivors had normal neurological outcomes at follow-up.

Conclusions:

• Intraventricular antibiotic chemotherapy is a valuable adjunct to systemic therapy for neonatal meningitis and ventriculitis.
• This combined approach significantly decreases mortality rates in affected infants.
• Further research into optimizing intraventricular antibiotic delivery and monitoring is warranted.